Felipe
Prosper Cardoso
Consultor Médico
![Foto de Felipe](/img/nophoto.png)
![Foto de Hospital Universitario Reina Sofia](/img/noimage_org.png)
Hospital Universitario Reina Sofia
Córdoba, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (40)
2023
-
AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity
Biomedicine and Pharmacotherapy, Vol. 169
-
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia
British Journal of Haematology
2022
2021
-
Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial
Blood Advances, Vol. 5, Núm. 3, pp. 760-770
-
The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the pethema-flugaza phase 3 clinical trial
Cancers, Vol. 13, Núm. 10
2012
-
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
Leukemia, Vol. 26, Núm. 7, pp. 1517-1526
2011
-
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family
British Journal of Haematology, Vol. 155, Núm. 1, pp. 73-83
-
Epigenetic activation of SOX11 in Lymphoid Neoplasms by Histone modifications
PLoS ONE, Vol. 6, Núm. 6
-
Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in Acute Lymphoblastic Leukemia
PLoS ONE, Vol. 6, Núm. 2
-
LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome
Haematologica, Vol. 96, Núm. 7, pp. 980-986
2010
-
DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia
PLoS ONE, Vol. 5, Núm. 8
-
Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia
Cancer Science, Vol. 101, Núm. 2, pp. 425-432
-
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
Blood, Vol. 116, Núm. 14, pp. 2531-2542
2009
-
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms
PLoS ONE, Vol. 4, Núm. 9
-
Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia
European Journal of Cancer, Vol. 45, Núm. 10, pp. 1877-1889
-
Epigenetic regulation of microRNA expression in colorectal cancer
International Journal of Cancer, Vol. 125, Núm. 11, pp. 2737-2743
-
Epigenetic signatures associated with different levels of differentiation potential in human stem cells
PLoS ONE, Vol. 4, Núm. 11
-
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia
Cancer Research, Vol. 69, Núm. 10, pp. 4443-4453
-
MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
Molecular Cancer, Vol. 8, pp. 69
2008
-
BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia
British Journal of Haematology, Vol. 142, Núm. 4, pp. 571-582